abstract Background: Autism spectrum disorder (ASD) is a serious neurodevelopmental disorder that impairs a child's ability to communicate with others. It also includes restricted repetitive behaviors, interests and activities. Symptoms manifest before the age of 3. In the previous studies, we found structural abnormalities of the temporal lobe cortex. High spine densities were most commonly found in ASD subjects with lower levels of cognitive functioning. In the present study, we retrospectively analyzed medical records in relation to the neonatal levels of total serum bilirubin (TSB), neuron-specific enolase (NSE), creatine kinase brain band isoenzyme (CK-BB), and neonatal behavior in ASD patients from Southern China. Methods: A total of 80 patients with ASD (ASD group) were screened for this retrospective study. Among them, 34 were low-functioning ASD (L-ASD group) and 46 were high-functioning ASD (H-ASD group). Identification of the ASD cases was confirmed with a Revised Autism Diagnostic Inventory. For comparison with ASD cases, 80 normal neonates (control group) were selected from the same period. Biochemical parameters, including TSB, NSE and CK-BB in the neonatal period and medical records on neonatal behavior were collected. Results: The levels of serum TSB, NSE and CK-BB in the ASD group were significantly higher when compared with those from the control group (P < 0.01, or P < 0.05). The amounts of serum TSB, NSE and CK-BB in the L-ASD group were significantly higher when compared with those in the H-ASD group (P < 0.01, or P < 0.05). The Neonatal Behavioral Assessment Scale (NBAS) scores in the ASD group were significantly lower than that in the control group (P < 0.05). Likewise, the NBAS scores in the L-ASD group were significantly lower than that in the H-ASD group (P < 0.05). There was no association between serum TSB, NSE, CK-BB and NBAS scores (P > 0.05) in the ASD group. Conclusions: The neonatal levels of TSB, NSE and CK-BB in ASD from Southern China were significantly higher than those of healthy controls. These findings need to be investigated thoroughly by future studies with large sample.
Introduction
Autism spectrum disorder (ASD) comprises a family of developmental disabilities characterized by behavioral abnormalities that include language delays, difficulties in social interactions, and repetitive or stereotyped behaviors [1, 2] . The majority of structural brain alterations in individuals with ASD identified in postmortem studies have been found both in cortical and non-cortical regions [3] [4] [5] [6] [7] [8] . In the previous studies [9, 10] , we examined postmortem brains of ASD individuals and found that cortical thickness values in ASD subjects decreased significantly with age. High spine densities were associated with decreased brain weights and were most commonly found in ASD subjects with lower levels of cognitive functioning.
The current high prevalence estimates for ASD suggest that some common perinatal and/or postnatal biological factors during the neonatal period may be responsible for this increased risk, but the relationship between abnormal brain structure and these factors in ASD patient are still unknown. Therefore, identification of biomarkers associated with these alterations may provide further insights into the disease mechanisms. In this study, we retrospectively analyzed hospital medical records in relation to the neonatal levels of total serum bilirubin (TSB), neuron-specific enolase (NSE), creatine kinase brain band isoenzyme (CK-BB), and neonatal behavior in ASD from Southern China. 
Materials and methods

Participants
Evaluation of neonatal behavior
The Neonatal Behavioral Assessment Scale 
Statistical methods
All data were expressed as the mean ± standard deviation (SD). Group differences were analyzed 
results
Comparison of serum TSB, NSE, CK-BB and NBAS scores between the ASD group and the control group in the neonatal period
The levels of serum TSB (μmol/L), NSE (μg/L) and CK-BB (mol/L) in the ASD group were significantly higher when compared with those in the control group (P < 0.01, or P < 0.05). The NBAS scores in the ASD group were significantly lower than that in the control group (P < 0.05, 
Correlation analysis
Pearson's correlation analysis revealed no association between serum TSB, NSE, CK-BB and NBAS scores (P > 0.05) in the ASD group (Fig. 3, A-E) . infantile ASD was 67% [20] . A prospective study from a Canadian group showed an association with ASD in the combined moderate and severe hyperbilirubinemia group [21] . In contrast, a large case-control study nested within the [30] reported higher levels of CK-MB in the youngest ASD group and low levels in the oldest ASD group. In this retrospective study, we found that the level of serum CK-BB in the ASD group was significantly higher than that in the control group, with significantly higher levels in the H-ASD group as compared with the L-ASD group.
Developed in 1973, the NBAS, which assesses both cortical and subcortical functions, is used to evaluate neurobehavioral outcomes in group and the high-functioning ASD (H-ASD) group (mean ± standard deviation). The amounts of serum TSB (μmol/L), NSE (μg/L) and CK-BB (mol/L) in the L-ASD group were significantly higher than those in the H-ASD group (*P < 0.05, **P < 0.01). The NBAS scores in the L-ASD group were significantly lower than those in the H-ASD group (*P < 0.05). CK-BB, creatine kinase brain band isoenzyme; NBAS, Neonatal Behavioral Assessment Scale; NSE, neuron-specific enolase; TSB, total serum bilirubin. Figure 1 . Serum TSB, NSE, CK-BB and NBAS scores in the ASD group and the control group (mean ± standard deviation) in the neonatal period. The amounts of serum TSB (μmol/L), NSE (μg/L) and CK-BB (mol/L) in the ASD group were significantly higher than those in the control group (*P < 0.05, **P < 0.01). The NBAS scores in the ASD group were significantly lower than in the control group. ASD, autism spectrum disorder; CK-BB, creatine kinase brain band isoenzyme; NBAS, Neonatal Behavioral Assessment Scale; NSE, neuron-specific enolase; TSB, total serum bilirubin.
cohort of singleton term infants born between
and 1998 in Kaiser Permanente Northern
California hospital, reported that children with any degree of bilirubin level elevation were not at increased risk of ASD [22] . A retrospective study from India showed that prematurity was associated with neonate hyperbilirubinemia in ASD [23] , but this association was not found in the meta-analysis [24] . In this retrospective study, we analyzed two different ASD groups and showed that the level of TSB in the neonatal period in the ASD group was higher than in the Translational Neuroscience NBAS is a reliable and useful instrument, and had been used by other studies of prenatal exposure and infant outcomes [31] [32] [33] . In this retrospective study, we found that the NBAS scores in the ASD group were significantly lower than those in the control group, again with significantly lower scores in the L-ASD group as compared with the H-ASD group. The underlying mechanisms nevertheless remain elusive and require further investigation.
Taken together, we proposed that higher levels of TSB may increase brain damage.
In turn, increased brain damage may cause elevated levels of serum NSE and serum CK-BB, which may be associated with abnormal brain structure and neonatal behavior in children with ASD from Southern China. Elucidation of molecular mechanisms underlying these changes may help develop novel therapeutic interventions for neuronal protection in ASD.
Unfortunately, the correlation analysis showed no association between serum TSB, NSE, CK-BB and NBAS scores in the ASD group. Therefore, these findings need to be investigated thoroughly by future studies with larger sample sizes.
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